StockData
HUTCHMED (China) Ltd logo

HUTCHMED (China) Ltd (HCM) stock

HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 5, 2026Score 5/30
$14.40−0.33 (-2.24%)

Close on Nov 17, 2026Market cap $2.51BP/E 5.5Yield –

HUTCHMED (China) total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

HUTCHMED (China)'s total debt was $116.91M at Jun 30, 2026. For fiscal 2025 it was $118.13M, up 11.3% from the year before. Over ten years it grew 16.0% a year on average. The highest annual figure on record is $118.13M in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$118.13M+11.3%
FY2024Dec 31, 2024$106.18M-3.9%
FY2023Dec 31, 2023$110.50M+510.4%
FY2022Dec 31, 2022$18.10M-32.7%
FY2021Dec 31, 2021$26.91M+0.2%
FY2020Dec 31, 2020$26.86M+0.2%
FY2019Dec 31, 2019$26.82M+0.3%
FY2018Dec 31, 2018$26.74M-10.8%
FY2017Dec 31, 2017$29.99M-35.9%
FY2016Dec 31, 2016$46.79M+74.8%
FY2015Dec 31, 2015$26.77M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$116.91M+7.7%
Q4 FY2025Dec 31, 2025$118.13M+6.9%
Q2 FY2025Jun 30, 2025$119.05M+196.5%
Q4 FY2024Dec 31, 2024$106.18M+486.5%
Q2 FY2024Jun 30, 2024$108.57M+25873.2%
Q4 FY2023Dec 31, 2023$110.50M+310.7%
Q2 FY2023Jun 30, 2023$40.15M+49.3%
Q4 FY2022Dec 31, 2022$18.10M-32.6%
Q2 FY2022Jun 30, 2022$418.00K-98.4%
Q4 FY2021Dec 31, 2021$26.91M+0.3%
Q2 FY2021Jun 30, 2021$26.88M+0.4%
Q4 FY2020Dec 31, 2020$26.86M+0.5%
Q2 FY2020Jun 30, 2020$26.84M+0.6%
Q4 FY2019Dec 31, 2019$26.82M-10.6%
Q1 FY2019Mar 31, 2019$26.76M-42.9%
Q4 FY2018Dec 31, 2018$26.74M-42.8%
Q2 FY2018Jun 30, 2018$26.69M-0.3%
Q4 FY2017Dec 31, 2017$29.99M–
Q2 FY2017Jun 30, 2017$46.85M–
Q4 FY2016Dec 31, 2016$46.79M–
Q4 FY2015Dec 31, 2015$26.77M–

More HUTCHMED (China) figures

See a number that looks wrong?